本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Edgewise Therapeutics, Inc.

44.95
+1.323.03%
成交量:109.14萬
成交額:4,881.44萬
市值:48.82億
市盈率:-24.30
高:45.38
開:43.78
低:43.63
收:43.63
52周最高:48.40
52周最低:13.85
股本:1.09億
流通股本:8,817.09萬
量比:0.82
換手率:1.24%
股息:- -
股息率:- -
每股收益(TTM):-1.8502
每股收益(LYR):-1.6302
淨資產收益率:-38.03%
總資產收益率:-25.03%
市淨率:10.89
市盈率(LYR):-27.57

資料載入中...

2024/09/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/12

重要事件披露

Form 8-K - Current report
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/06/11

重要事件披露

Form 8-K - Current report
2024/05/10

重要事件披露

Form 8-K - Current report
2024/05/09

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/07

重要事件披露

Form 8-K - Current report
2024/02/22

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/01

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]